The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
-
Published:2021-08-06
Issue:9
Volume:12
Page:2499-2515
-
ISSN:1869-6953
-
Container-title:Diabetes Therapy
-
language:en
-
Short-container-title:Diabetes Ther
Author:
Katakami NaotoORCID, Mita Tomoya, Yoshii Hidenori, Shiraiwa Toshihiko, Yasuda Tetsuyuki, Okada Yosuke, Torimoto Keiichi, Umayahara Yutaka, Kaneto Hideaki, Osonoi Takeshi, Yamamoto Tsunehiko, Kuribayashi Nobuichi, Maeda Kazuhisa, Yokoyama Hiroki, Kosugi Keisuke, Ohtoshi Kentaro, Hayashi Isao, Sumitani Satoru, Tsugawa Mamiko, Ryomoto Kayoko, Taki Hideki, Nakamura Tadashi, Kawashima Satoshi, Sato Yasunori, Watada Hirotaka, Shimomura Iichiro, Hayashi I., Tsugawa M., Yokoyama H., Yoshii H., Komiyama K., Mita T., Shimizu T., Yamamoto T., Kawashima S., Nakamura T., Kamei S., Kinoshita T., Shimoda M., Maeda K., Kosugi K., Yoshii H., Ishida H., Osonoi T., Saito M., Tamazawa A., Sumitani S., Fujiki N., Fujita Y., Shimizu S., Umayahara Y., Kato K., Irie Y., Kataoka R., Yasuda T., Kiyohara Y., Ohashi M., Ryomoto K., Takahi Y., Fujishima Y., Fujita Y., Fukuhara A., Fukui K., Hosokawa Y., Imagawa A., Iwahashi H., Mukai K., Katakami N., Katsura T., Kawamori D., Kimura T., Kobayashi S., Kozawa J., Kubo F., Maeda N., Matsuoka T., Miyashita K., Nakata S., Ninomiya H., Nishizawa H., Okuno Y., Otsuki M., Sakamoto F., Sasaki S., Sato I., Shimo N., Shimomura I., Takahara M., Takano T., Tokunaga A., Uno S., Yamaoka M., Yoneda S., Ohtoshi K., Shiraiwa T., Hajime M., Koikawa K., Kuno F., Kurozumi A., Matsushita K., Narisawa M., Tanaka K., Sugai K., Okada Y., Torimoto K.,
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference34 articles.
1. Ishii H, Anderson JH Jr, Yamamura A, Takeuchi M, Ikeda I. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Res Clin Pract. 2008;81:169–78. 2. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41. 3. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:211721–8. 4. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644–57. 5. Wiviott SD, Raz I, Bonaca MP, et al; DECLARE–TIMI 58 Investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347–57.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|